Perrigo obtained federal approval for its fluticasone propionate lotion in the 0.05% strength to address inflammatory and pruritic manifestations of atopic dermatitis in pediatric patients ages 1 and older. The drug is a generic copy of PharmaDerm's Cutivate.
Perrigo's generic dermatitis drug gains FDA nod
SmartBrief Job Listings for Health Care
|Chief Operating Officer||
Presence Health Partners
|Des Plaines, IL|
|Sr. Business Systems Analyst||
|Sr. Reimbursement Analyst||
Olympus America Inc.
|Staff VP Medical Policy Development-81321||
|Strategic Partner Relationship Executive||
Geisinger Health System